In Vivo Assessment of Drug Interactions Effects of Sitagliptin on Other Drugs In clinical studies, as described below, sitagliptin did not meaningfully alter the pharmacokinetics of metformin, glyburide, simvastatin, rosiglitazone, warfarin, or oral contraceptives, providing in vivo evidence of a low propensity for causing drug interactions with substrates of CYP3A4, CYP2C8, CYP2C9, and organic cationic transporter (OCT)
Blood sugar readings may look better, but the root cause, insulin resistance, continues to drive fat storage, inflammation, and fatigue beneath the surface
Riboflavin (Vitamin B2) B2 supports metabolism, helping your body convert carbs and fats into more energy
In particular, KEAP1 and NRF2 mutations are encountered in 2030% of non-small cell lung cancers (Cancer Genome Atlas Research Network 2012